- Home
- GRCE vs FGF Comparison
GRCE vs FGF Comparison
Compare GRCE & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- FGF
- Stock Information
- Founded
- GRCE 2002
- FGF 2012
- Country
- GRCE United States
- FGF United States
- Employees
- GRCE N/A
- FGF N/A
- Industry
- GRCE
- FGF Property-Casualty Insurers
- Sector
- GRCE
- FGF Finance
- Exchange
- GRCE NYSE
- FGF Nasdaq
- Market Cap
- GRCE 42.1M
- FGF 20.9M
- IPO Year
- GRCE N/A
- FGF N/A
- Fundamental
- Price
- GRCE $2.98
- FGF $16.50
- Analyst Decision
- GRCE Strong Buy
- FGF
- Analyst Count
- GRCE 1
- FGF 0
- Target Price
- GRCE $12.00
- FGF N/A
- AVG Volume (30 Days)
- GRCE 54.5K
- FGF 4.9K
- Earning Date
- GRCE 06-23-2025
- FGF 08-13-2025
- Dividend Yield
- GRCE N/A
- FGF N/A
- EPS Growth
- GRCE N/A
- FGF N/A
- EPS
- GRCE N/A
- FGF N/A
- Revenue
- GRCE N/A
- FGF $13,260,000.00
- Revenue This Year
- GRCE N/A
- FGF N/A
- Revenue Next Year
- GRCE N/A
- FGF N/A
- P/E Ratio
- GRCE N/A
- FGF N/A
- Revenue Growth
- GRCE N/A
- FGF N/A
- 52 Week Low
- GRCE $1.75
- FGF $14.21
- 52 Week High
- GRCE $4.97
- FGF $38.40
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- FGF 37.09
- Support Level
- GRCE N/A
- FGF $15.93
- Resistance Level
- GRCE N/A
- FGF $17.98
- Average True Range (ATR)
- GRCE 0.00
- FGF 0.47
- MACD
- GRCE 0.00
- FGF -0.13
- Stochastic Oscillator
- GRCE 0.00
- FGF 2.35
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segments includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.